Sichuan Languang Development Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sichuan Languang Development Co Ltd with three other
companies in this sector in China:
Guangzhou Baiyunshan Pharmceutical Holdings Co Ltd
sales of 20.03 billion Chinese Renmimbi [US$3.10 billion]
of which 39%
Shanghai Fosun Pharmaceutical (Group) Company Limited
(14.51 billion Chinese Renmimbi [US$2.25 billion]
of which 70%
was Pharmaceutical Manufacturing and R&D), and
Tasly Pharmaceutical Group Company Limited
(13.95 billion Chinese Renmimbi [US$2.16 billion]
of which 51%
was Medicine Commerce).
Sichuan Languang Development Co Ltd reported sales of 19.95 billion Chinese Renmimbi (US$3.09 billion)
December of 2016.
increase of 19.2%
versus 2015, when the company's sales were 16.74 billion Chinese Renmimbi.
Sales at Sichuan Languang Development Co Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 6,227%).
Sales of Pharmaceutical Sale saw an increase
23.7% in 2016, from
448.67 million Chinese Renmimbi to 554.93 million Chinese Renmimbi.